Mainstream reporters helped spread VeriChip “lies,” Spychips author says
(Katherine Albrecht, the world’s most influential opponent to the use of RFID tags for tracking humans, is driving another nail into VeriChip, and its MSM dupes, for promoting subcutaneous chipping. Photo: Anne Hellmond)
I always tell my journalism students that objectivity should not come at the expense of the truth.
Still, many reporters appear to take the corporate suits at their word, despite compelling evidence from grassroots technology opponents (link, excerpt, below).
A simple denial from VeriChip, for example, seemed enough to balance the scales for reporters at Time Magazine, Business Week, and RFID Journal, after Albrecht told an AP reporter about animal studies strongly suggestive of a chip-cancer link.
Industry and government are fairly adept at damage control. After I wrote a Wired story about Homeland Security human tracking scheme in early 2005, the agency enlisted a computer rag hack in an attempt to discredit my original piece.
VeriChip similarly reached out to Time magazine to soften the blow of the surprising findings of cancer in animals bearing microchip implants, which Albrecht brought to light.
Albrecht believes the VeriChip might be a precursor to the Mark of the Beast described in the Book of Revelation.
Verichip Cancer Report
VeriChip’s media efforts have done little to salvage the company’s public image or its financial performance, both of which plummeted after research linking the implantable microchip to cancer was first widely revealed by the Associated Press in September 2007. The same company that once predicted revenues in the “billions” earned just $3,000 from its microchip implant operations in the first quarter of 2008, as patients shun the device that many are now calling the “cancer chip.”
Investors have also distanced themselves from the failing company, with VeriChip’s stock plummeting from a high of $10.62 last year to just over $2.00 today.